SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-028059
Filing Date
2023-08-14
Accepted
2023-08-14 08:15:33
Documents
50
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1046136
2 ex31-1.htm EX-31.1 20852
3 ex31-2.htm EX-31.2 20936
4 ex32-1.htm EX-32.1 8357
5 ex32-2.htm EX-32.2 8903
  Complete submission text file 0001493152-23-028059.txt   3481808

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT indp-20230630.xsd EX-101.SCH 23746
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT indp-20230630_cal.xml EX-101.CAL 40159
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT indp-20230630_def.xml EX-101.DEF 66130
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT indp-20230630_lab.xml EX-101.LAB 218774
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT indp-20230630_pre.xml EX-101.PRE 166927
44 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 321449
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40652 | Film No.: 231166461
SIC: 2834 Pharmaceutical Preparations